23 Aug 2024 | 02:47 PM UTC
Cote d'Ivoire: Confirmed monkeypox (mpox) cases reported in multiple areas in August /update 1
Confirmed monkeypox (mpox) cases reported in Cote d'Ivoire in August. Exercise basic health precautions.
Health officials have reported confirmed monkeypox (mpox) cases in multiple areas in Cote d'Ivoire, with an additional 22 cases reported Aug. 2-20, bringing the total to 28 confirmed mpox cases since July 1. This is compared to no cases reported for 2023. Cases have been reported across the country, with some cases identified in the Abidjan, Sakassou, and Tabou departments. Local health officials recommend that the population consult their nearest health center as quickly as possible if experiencing any symptoms. The Ministry of Health has implemented a response strategy, including activating the Public Health Emergency Operations Center, strengthening infection prevention and control measures in health facilities, and strengthening epidemiological surveillance for the early detection of suspected cases and contact tracing. As disease surveillance and contact tracing continue, officials will likely identify additional cases in the coming weeks. This report represents the most up-to-date information as of Aug. 23.
Practice basic health precautions, including frequent handwashing with soap and water, covering the nose and mouth when coughing, and avoiding obviously ill individuals. Avoid overcrowded areas such as nightclubs and consider using safe sexual practices such as physical barriers (condoms) in countries reporting mpox transmission. Seek medical attention if symptoms develop within two weeks of being in affected areas, especially if you have had one or more new sexual partners. Vaccines are available.
On Aug. 14, the WHO declared the mpox outbreak in Africa a Public Health Emergency of International Concern (PHEIC). The African region has seen an unprecedented increase in mpox cases since early 2024, with previously unaffected countries like Burundi, Cote d’Ivoire, Kenya, Rwanda, and Uganda reporting cases. The WHO's declaration aims to prompt a coordinated international response, improve surveillance, accelerate vaccine distribution, enhance public health measures, and mobilize resources to control the outbreak.
Mpox is a viral illness caused by the monkeypox virus, a species of the genus Orthopoxvirus. Mpox is mainly transmitted to humans through direct contact with infected individuals (including intimate or sexual contact), infected animals, or through contact with contaminated materials. Human-to-human transmission primarily occurs through close personal contact with an infected individual via respiratory droplets, direct contact with bodily fluids, or indirect contact with lesion material (e.g., contaminated clothing or bedding). Symptoms typically appear 3-17 days after exposure but can develop up to 21 days after exposure. Symptoms generally include fever, headache, muscle and back aches, swollen lymph nodes, chills, exhaustion, and a distinctive rash characterized by lesions that progress through several stages before falling off.
